A Pint for Kim Blood Drive Breaks State Record Fifth Year in a Row with More than 700 Donors Showing Up to Give Blood
May 13, 2024 14:43 ET
|
A Pint for Kim
NAPERVILLE, Ill., May 13, 2024 (GLOBE NEWSWIRE) -- A Pint For Kim, a national grassroots movement created in 2020 in honor of mom Kimberly Sandford who lost her eight-year battle with a rare cancer,...
TransCode Therapeutics Open Letter to Shareholders
May 13, 2024 08:30 ET
|
TransCode Therapeutics, Inc.
An Open Letter to Shareholders regarding a Reverse Stock Split
Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
May 13, 2024 05:30 ET
|
Hummingbird Bioscience
Hummingbird Bioscience will present next-generation antibody-drug conjugate capabilities at PEGS Boston 2024 for the first time.
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
May 10, 2024 10:58 ET
|
King Faisal Specialist Hospital & Research Centre
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
May 09, 2024 16:05 ET
|
Vor Biopharma
On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to the...
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
May 09, 2024 08:50 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the...
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
May 09, 2024 08:00 ET
|
Bionano Genomics
Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
May 09, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
May 08, 2024 16:02 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”
May 08, 2024 09:25 ET
|
Lixte Biotechnology Holdings, Inc.
Recent Findings Relate to LIXTE’s Lead Clinical Compound, LB-100, to be Presented at Workshop on May 9 and 10 at Harvard’s Dana Farber Cancer Institute in Boston PASADENA, CA, May 08, 2024 (GLOBE...